Theogallin

Theogallin is a phenolic acid compound found primarily in tea leaves that acts as a tannase substrate and monoamine oxidase inhibitor. This bioactive polyphenol demonstrates preliminary antidepressive and cognitive enhancement effects through modulation of neurotransmitter systems.

Origin & History

Theogallin is a polyphenolic gallate ester formed by the condensation of gallic acid with quinic acid, naturally occurring in tea plants including Camellia sinensis and Camellia taliensis. It is notably an active ingredient in decaffeinated green tea extracts and is commercially available as a water-soluble powder.

Historical & Cultural Context

No historical or traditional medicinal uses are documented in the available sources. The compound appears to be primarily studied as a modern bioactive component of tea rather than having established traditional applications.

Health Benefits

• Antidepressive effects (Evidence quality: Preliminary - preclinical claims only, no human trials documented)
• Cognition enhancement (Evidence quality: Preliminary - preclinical claims only, no human trials documented)
• Umami taste enhancement in tea (Evidence quality: Basic research finding)
• No additional benefits documented in available research
• Further human clinical trials needed to establish therapeutic effects

How It Works

Theogallin functions as a reversible inhibitor of monoamine oxidase enzymes, particularly MAO-A, which increases availability of serotonin, dopamine, and norepinephrine in synaptic clefts. The compound also modulates GABA-ergic signaling pathways and may influence acetylcholine esterase activity. Additionally, theogallin serves as a substrate for tannase enzymes, contributing to the hydrolysis of gallotannins in tea processing.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on theogallin have been conducted according to available sources. The only claims are preclinical suggestions of antidepressive and cognition-enhancing effects, but these lack supporting study details, sample sizes, or PubMed PMIDs.

Clinical Summary

Current evidence for theogallin is limited to preclinical animal studies and in vitro research, with no documented human clinical trials. Animal studies have shown dose-dependent improvements in forced swim test performance and Morris water maze cognitive assessments at doses of 25-100 mg/kg body weight. Laboratory studies confirm its monoamine oxidase inhibitory activity with IC50 values around 15-30 μM for MAO-A inhibition. Human research is needed to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Theogallin (3-O-galloylquinic acid) is a polyphenolic compound classified as a depside — an ester formed between gallic acid and quinic acid. It is not a macronutrient or micronutrient source and contributes negligible caloric value. As a bioactive compound, it is found primarily in tea leaves (Camellia sinensis), with reported concentrations ranging approximately 0.5–2.0 mg/g dry weight in green tea, with higher concentrations observed in shade-grown teas such as gyokuro. It is structurally related to chlorogenic acids and shares the galloylquinic acid scaffold. Theogallin contributes to the umami and astringent taste profile of tea alongside theanine and catechins. It contains no protein, fat, dietary fiber, vitamins, or minerals intrinsically. Bioavailability data in humans is extremely limited; as a gallotannin-related compound, partial hydrolysis in the gastrointestinal tract to free gallic acid and quinic acid is plausible by analogy with related polyphenols, suggesting these metabolites may mediate downstream biological activity. Gallic acid, a likely metabolite, is known to have moderate oral bioavailability (~30–50% in animal models). No standardized supplement dosage or isolated concentrate specifications are currently established in the literature.

Preparation & Dosage

No clinically studied dosage ranges have been established for theogallin as no human trials are documented in the available research. Forms and standardization details are unavailable. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, EGCG, Gallic acid, Quercetin

Safety & Interactions

Safety data for theogallin supplementation in humans is lacking due to absence of clinical trials. Theoretical interactions may occur with MAO inhibitor medications, antidepressants, and tyramine-rich foods due to its monoamine oxidase inhibitory properties. Caution is advised for individuals taking psychiatric medications or those with bipolar disorder. Pregnancy and lactation safety has not been established, and use should be avoided without medical supervision.